Varvee Global Limited (VGL) Posts Strong Operational Profit & EBDITA for Q2FY26: +80% Revenue Growth, 49.8% EBITDA Margin; PAT +23.5% YoY; H1 PAT +15.7% and Attaining Near-Zero Debt
AHMEDABAD, India, Nov. 13, 2025 /PRNewswire/ -- VGL Limited ("VGL" or the…
ProFrac Holding Corp. Reports Third Quarter 2025 Results
WILLOW PARK, Texas--(BUSINESS WIRE)--ProFrac Holding Corp. (NASDAQ: ACDC) (“ProFrac”, or the “Company”)…
LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase…
Innoviti Posts 35% Revenue Growth in FY25
Strong execution across all product lines led to gross margin improvement by…
DATROWAY Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival as First-Line Therapy for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02
Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only therapy to…
Volvo Trucks: Advancing Road Safety Across Southeast Asia
Collaboration with Schools and Communities to Protect Children and Vulnerable Road Users…
Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94%…
Urban Company Limited Launches ‘Revamp’: Transform Any Wall, Any Space in a Day
MUMBAI, India, Aug. 27, 2025 /PRNewswire/ -- Urban Company Limited today announced the…
Novo Nordisk A/S: Wegovy approved in the US for the treatment of MASH
Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US…
Spineway : H1 2025 results – Continued improvement in results and financial position
Press release Ecully, July 30, 2025 – 7 p.m. SPINEWAY H1 2025…